Yokoe, Takamichi http://orcid.org/0000-0001-7068-7117
Kurozumi, Sasagu
Nozawa, Kazuki
Ozaki, Yukinori
Maeda, Tetsuyo
Yazaki, Shu
Onishi, Mai
Fujimoto, Akihiro
Nakayama, Sayuka
Tsuboguchi, Yuko
Iwasa, Tsutomu
Sakai, Hitomi
Ogata, Misato
Terada, Mitsuo
Nishimura, Meiko
Onoe, Takuma
Masuda, Jun
Kurikawa, Michiko
Isaka, Hirotsugu
Hagio, Kanako
Shimomura, Akihiko
Okumura, Yuta
Futamura, Manabu
Shimokawa, Mototsugu
Takano, Toshimi
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 24 June 2020
Accepted: 19 November 2020
First Online: 2 January 2021
Compliance with ethical standards
:
: Takamichi Yokoe has received lecture honoraria from Kyowa Kirin, Pfizer, and Eisai. Yukinori Ozaki has received honoraria from Chugai. Takuma Onoe has received lecture honoraria from Bristol-Myers Squibb. Mototsugu Shimokawa has received a consulting fee from Sysmex. Toshimi Takano received honoraria from Daiichi-Sankyo, Chugai, Kyowa Kirin, Eisai, Pfizer, Eli Lilly, and Celltrion, and research funding from Daiichi-Sankyo, Chugai, Kyowa Kirin, Eisai, Ono, Bristol-Myers Squibb, MSD, Merck Serono, Taiho, and Novartis. All remaining authors have no conflicts of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. Ethics approval and consent were obtained from the review board in each institution.
: Patient approval and consent were obtained through opt-out.